Biogen, Inc. (BIIB)
$243.78 2.03 (0.84%)
16:34 EST BIIB Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 51.44B
PE Ratio 17.41
Volume (Avg. Vol.) 699,200
Day's Range 241.00 - 244.33
52-Week Range 223.25 - 374.99
Dividend & Yield N/A (N/A)
BIIB Stock Predictions, Articles, and Biogen, Inc. News
- From InvestorPlace
- From the Web
Biogen, Peloton, General Motors and Wendy's were our top stock trades for Thursday. Now, let's look at the charts to see what's going on.
Warren Buffett stocks perhaps aren't what they once were. But these 8 names, including AAPL stock, look like the best of the Berkshire portfolio.
Biogen earnings on Wednesday have BIIB stock higher after the company crushed Wall Street's expectations for EPS and revenue for the quarter.
Biogen opened higher by around 10% on news of its Alzheimer's drug. By the end of day, BIIB stock gave up a bulk of its gains. What gives?
Snap, Nio, Biogen and Twitter were our top stock trades for Thursday. That said, let's see how the charts are setting up after some big moves.
Biogen (BIIB) news for Thursday concerning a lost court ruling surrounding its multiple sclerosis drug has BIIB stock taking a beating.
Biogen has solid and consistent revenue, profit and cash flow. But Biogen stock has a low valuation because it has no growth.
Biotech stocks are in the spotlight in 2020, with the race to develop testing, treatment and a vaccine for Covid-19 driving rapid growth.
Aging seniors have been put firmly in the crosshairs of the novel coronavirus. These 10 stocks to buy will benefit from this brutal reality.
Thursday's big stock charts feature names that released noteworthy earnings data.
Thursday's big stock charts feature names that outperformed during a major market surge.
Tuesday's big stock charts feature stocks holding support whose businesses could, and maybe should, hold up in the near term.
By Ian Cooper
One of the best ways to profit is to invest like Warren Buffett. Here are three Berkshire Hathaway stocks that he's watching now.
Ford and Disney sank on earnings, while oil demand could shrivel up in China. Here's what happened in the stock market today.
The only thing more important than what to buy is what not to buy. These biotech stocks are at the top of the avoid list. Here's why.
Wednesday's big stock charts highlight 3 stocks looking to break through resistance in a market that looks a bit shaky at the moment.
BOSTON, MA / ACCESSWIRE / November 25, 2020 / The Thornton Law Firm announces that a class action lawsuit has been filed on behalf of investors of Biogen Inc. (NADSAQ:BIIB). Investors who purchased BIIB stock or other securities between October 22, 2019 and November 6, 2020 may contact the Thornton Law Firm to obtain a copy of the complaint or to discuss the lead plaintiff process. Interested investors are encouraged to visit:
Navellier RatingsPowered by Portfolio Grader